Xeris Biopharma Holdings (XERS) Amortization - Intangibles (2021 - 2025)
Historic Amortization - Intangibles for Xeris Biopharma Holdings (XERS) over the last 5 years, with Q3 2025 value amounting to $2.7 million.
- Xeris Biopharma Holdings' Amortization - Intangibles changed 0.0% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.8 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $10.8 million for FY2024, which is 0.0% changed from last year.
- Latest data reveals that Xeris Biopharma Holdings reported Amortization - Intangibles of $2.7 million as of Q3 2025, which was down 0.0% from $2.7 million recorded in Q2 2025.
- Over the past 5 years, Xeris Biopharma Holdings' Amortization - Intangibles peaked at $2.7 million during Q1 2022, and registered a low of $550000.0 during Q4 2021.
- In the last 5 years, Xeris Biopharma Holdings' Amortization - Intangibles had a median value of $2.7 million in 2022 and averaged $2.6 million.
- Per our database at Business Quant, Xeris Biopharma Holdings' Amortization - Intangibles skyrocketed by 39290.91% in 2022 and then dropped by 3.69% in 2025.
- Xeris Biopharma Holdings' Amortization - Intangibles (Quarter) stood at $550000.0 in 2021, then soared by 392.91% to $2.7 million in 2022, then changed by 0.0% to $2.7 million in 2023, then changed by 0.0% to $2.7 million in 2024, then changed by 0.0% to $2.7 million in 2025.
- Its Amortization - Intangibles stands at $2.7 million for Q3 2025, versus $2.7 million for Q2 2025 and $2.7 million for Q1 2025.